Related Experiment Video

Updated: Apr 24, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

12.9K

Species-associated differences in the inhibition of propofol glucuronidation by magnolol

Lu Yang1, Liangliang Zhu2, Guangbo Ge3

  • 1School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, China.

Journal of the American Association for Laboratory Animal Science : JAALAS
|September 9, 2014
PubMed

Insights

Magnolol strongly inhibits propofol glucuronidation in humans but not in mice or rats. Animal models like pigs and macaques show varying inhibition, making them poor predictors of human responses.

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Toxicology

Background:

  • Magnolol, a key compound in herbal medicine, significantly inhibits propofol glucuronidation in human liver microsomes.
  • This inhibition occurs at nanomolar concentrations, suggesting a potent interaction.

Purpose of the Study:

  • To evaluate the inhibitory effects of magnolol on propofol glucuronidation across different animal species.
  • To compare the efficacy of animal models in predicting human magnolol-induced inhibition of propofol glucuronidation.

Main Methods:

  • Liver microsomes from Swiss-Hauschka mice, Sprague-Dawley rats, Chinese Bama pigs, and cynomolgus macaques were used.
  • Propofol glucuronidation was measured in the presence of magnolol (10 μM).
  • Enzyme kinetics, including inhibition constants (Ki), were determined for significant interactions.

Main Results:

  • Magnolol inhibited propofol glucuronidation in pigs (competitive, Ki = 1.7 μM) and cynomolgus macaques (noncompetitive, Ki = 3.4 μM).
  • No significant inhibition was observed in mouse or rat liver microsomes.
  • Inhibition constants in animal models were considerably higher than those observed in human liver microsomes.

Conclusions:

  • Magnolol's inhibition of propofol glucuronidation differs significantly across species.
  • The tested animal models (mice, rats, pigs, macaques) are not suitable for predicting magnolol's inhibitory effects on propofol glucuronidation in humans.
  • Differences in enzyme kinetics and expression levels likely contribute to interspecies variability.

More Related Videos

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

14.1K

Related Concept Videos

Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
767
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.4K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
799
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
2.2K
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
93
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K